Preclinical assessment of dual CYP26[A1/B1] inhibitor, DX308, as an improved treatment for keratinization disorders-Reference-Cited by-同舟云学术

Preclinical assessment of dual CYP26[A1/B1] inhibitor, DX308, as an improved treatment for keratinization disorders

Published:2021-03-26 Issue:2 Volume:1 Page:
ISSN:2690-442X
Container-title:Skin Health and Disease
language:en
Short-container-title:Skin Health and Disease

Author:

Veit J.G.S.¹²³^ORCID,Poumay Y.²^ORCID,Mendes D.³^ORCID,Kreitinger J.³^ORCID,Walker L.³^ORCID,Paquet A.⁴^ORCID,Menigot C.⁴^ORCID,Zolezzi F.⁴^ORCID,Paller A.S.⁵^ORCID,Diaz P.¹³^ORCID

Affiliation:

1. Department of Biomedical and Pharmaceutical Sciences University of Montana Missoula Montana USA

2. URPHYM‐NARILIS University of Namur Namur Belgium

3. R&D DermaXon LLC Missoula Montana USA

4. Syneos Health Biot France

5. Department of Dermatology Northwestern University Feinberg School of Medicine Chicago Illinois USA

Publisher

Wiley

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/ski2.22

Reference53 articles.

1. Congenital Ichthyosis: An Overview of Current and Emerging Therapies

2. Darier??s Disease

3. Topical treatment of ichthyoses and Darier's disease with 13-cis-retinoic acid

4. Isotretinoin treatment of Darier's disease

5. Successful treatment of linear Darier's disease with topical adapalene

Cited by 2 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. A versatile, bioengineered skin reconstruction device designed for use in austere environments;Frontiers in Bioengineering and Biotechnology;2023-06-08

2. An In Vitro Model for Characterization of Drug Permeability across the Tympanic Membrane;Pharmaceuticals;2022-09-07